Anixa shares Phase 1 data on breast cancer vaccine and CAR-T therapy
Anixa Biosciences (NASDAQ: ANIX) presented data from two clinical-stage immunotherapy programs at the New York Academy of Sciences' Frontiers in ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
